Sort
39,280 grants matching “leukemia”
Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML
$628,352Yang Liu · Children'S Research Institute · U01 · FY2015 · CA
Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia
$628,338Daniel Bachovchin · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Brain Tumors - Immunological and Biological Studies
$628,277Duke University · R37 · FY2004 · CA
Interactions of retroviral and host proteins guided by advanced modeling
$628,000Monica J Roth · Rutgers Biomedical And Health Sciences · R35 · FY2024 · GM
Interactions of retroviral and host proteins guided by advanced modeling
$628,000Monica J Roth · Rutgers Biomedical And Health Sciences · R35 · FY2025 · GM
Characterization of Diverse Pediatric Cancers in LMIC Using Low-Cost Nanopore Sequencing
$627,939Jeremy R Wang · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Robust and Rapid 3D High-Resolution Cranial bone imaging for pediatric patients using MRI
$627,926Hongyu An · Washington University · R01 · FY2023 · EB
iPSC-based blood regenerative therapies for AIDS
$627,832Igor I Slukvin · University Of Wisconsin-Madison · R01 · FY2014 · HL
Intestinal tissue intrinsic mechanisms in regulation of GI GVHD
$627,781Pavan Reddy · Baylor College Of Medicine · R01 · FY2022 · AI
Oogenic JNK in gonadotoxic chemotherapy-induced primary ovarian insufficiency
$627,728Shuo Xiao · Rutgers Biomedical And Health Sciences · R01 · FY2024 · HD
Project 2: Microenvironmental and inflammatory mechanisms in MDM4-driven AML pathogenesis.
$627,482Ulrich Steidl · Columbia University Health Sciences · P01 · FY2025 · CA
Clinical Program
$627,478William George Wierda · University Of California, San Diego · P01 · FY2013 · CA
Magnetic Sorter Channels for Stem Cells
$627,436Techshot, Inc. · R44 · FY2005 · HL
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
$627,308Eric Jessen Chow · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Promoting Treatment Adherence in Adolescent Leukemia
$627,304Dennis D Drotar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2010 · CA
A Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients
$627,270Aaron D Schuler · Syntrix Biosystems, Inc. · R44 · FY2025 · CA
Role of Phase separation by fusion oncoproteins in oncogenesis
$627,217Richard W Kriwacki · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy
$627,158Daniel Fowler · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
NCI Community Oncology Research Program (NCORP) Community Sites
$626,981Albert Denittis · Lankenau Institute For Medical Research · UG1 · FY2015 · CA
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
$626,964Ross L Levine · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Targeting the menin-MLL1 complex for new therapeutics
$626,786Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
PRE-AND POSTGRADUATE TRAINING IN MOLECULAR HEMATOLOGY
$626,730J Evan Sadler · Washington University · T32 · FY2017 · HL
Identifying Multi-Level Predictors and Outcomes of Oral Anticancer Medication Adherence Initiation and Persistence among Patients with Hematologic Malignancies
$626,631Sarah M. Belcher · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
$626,526Daniel J. Powell · University Of Pennsylvania · R01 · FY2024 · CA
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
$626,401Ross L Levine · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA